Anixa Biosciences Inc (ANIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 10/31
| 10-2020 | 10-2019 | 10-2018 | 10-2017 | 10-2016 | |
| Sales | 0 | 250 | 1,113 | 363 | 300 |
| Gross Profit | N/A | 250 | 1,113 | 363 | 300 |
| Operating Expenses | 9,978 | 12,140 | 15,402 | 6,438 | 4,809 |
| Operating Income | -9,978 | -11,890 | -14,289 | -6,076 | -4,509 |
| Interest Expense | 0 | 0 | 0 | 501 | 520 |
| Other Income | -114 | 71 | 46 | 1,567 | 13 |
| Pre-tax Income | -10,092 | -11,819 | -14,243 | -5,009 | -5,016 |
| Net Income Continuous | -10,092 | -11,819 | -14,243 | -5,009 | -5,016 |
| Minority Interests | -74 | -172 | -247 | N/A | N/A |
| Net Income | $-10,018 | $-11,647 | $-13,996 | $-5,009 | $-5,016 |
| EPS Basic Total Ops | -0.45 | -0.59 | -0.79 | -0.58 | -0.57 |
| EPS Basic Continuous Ops | -0.45 | -0.60 | -0.81 | -0.41 | -0.57 |
| EPS Diluted Total Ops | -0.45 | -0.59 | -0.79 | -0.58 | -0.57 |
| EPS Diluted Continuous Ops | -0.45 | -0.60 | -0.81 | -0.41 | -0.57 |
| EPS Diluted Before Non-Recurring Items | -0.45 | -0.59 | N/A | N/A | N/A |
| EBITDA(a) | $-9,888 | $-11,424 | $-13,945 | $-5,707 | $-3,630 |